← Back
$AMRX All transactions

Amneal Pharmaceuticals, Inc.

A

$ Value

$0

Shares

544,663

Price

$0

Filed

Mar 27

Insider

Name

Patel Chirag K.

Title

President & Co-CEO

CIK

0001738701

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

544,663

Footnotes

Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. | Represents a performance-based restricted stock unit grant of 544,663 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2029, the last day of the performance period.

Filing Info

Accession No.

0001628280-26-021742

Form Type

4/A

Issuer CIK

0001723128

Patel Chirag K.'s History

Date Ticker Type Value
2026-03-02 AMRX A $0

Other Insiders at AMRX (90d)

Insider Bought Sold Last
Patel Chintu
Co-CEO
2026-03-02